Stockscreener 앱 받기
10.39
2.81%
-0.30
시간 외 거래:
10.59
0.20
+1.92%
전일 마감가:
$10.69
열려 있는:
$10.66
하루 거래량:
240.48K
Relative Volume:
1.51
시가총액:
$225.43M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-11.12%
1개월 성능:
-35.39%
6개월 성능:
-19.21%
1년 성능:
+0.00%
1일 변동 폭
$9.90
$10.74
1주일 범위
$9.90
$12.16
52주 변동 폭
$4.88
$19.58
Aardvark Therapeutics Inc Stock (AARD) Company Profile
명칭
Aardvark Therapeutics Inc
전화
(858) 225-7696
주소
4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO
AARD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AARD
Aardvark Therapeutics Inc
|
10.39 | 231.90M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Aardvark Therapeutics Inc Stock (AARD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-29 | 개시 | Stifel | Buy |
| 2025-06-30 | 개시 | H.C. Wainwright | Buy |
| 2025-03-10 | 개시 | BofA Securities | Buy |
| 2025-03-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-03-10 | 개시 | Morgan Stanley | Overweight |
| 2025-03-10 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Aardvark Therapeutics Inc 주식(AARD)의 최신 뉴스
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Aardvark Therapeutics (Nasdaq: AARD) grants inducement options totaling 88,217 shares - Stock Titan
Real time social sentiment graph for Aardvark Therapeutics Inc.Weekly Market Report & Long Hold Capital Preservation Tips - newser.com
Is Aardvark Therapeutics Inc. forming a reversal patternEarnings Performance Report & Weekly Stock Performance Updates - newser.com
Will Aardvark Therapeutics Inc. stock attract ESG investorsNew Guidance & Intraday High Probability Alerts - newser.com
Aardvark Therapeutics (NASDAQ: AARD) sets Nov 11 & Nov 24 investor talks; live webcasts - Stock Titan
Is Aardvark Therapeutics Inc. stock undervalued vs historical averagesTrade Volume Report & Risk Controlled Daily Trade Plans - newser.com
Why Aardvark Therapeutics Inc. stock is seen as undervaluedQuarterly Growth Report & Free Safe Capital Growth Stock Tips - newser.com
Analyzing Aardvark Therapeutics Inc. with multi timeframe charts2025 Top Gainers & Reliable Volume Spike Alerts - newser.com
Will Aardvark Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Action & Target Return Focused Picks - newser.com
Is Aardvark Therapeutics Inc. stock attractive for income investorsJobs Report & Verified Momentum Stock Ideas - newser.com
Aardvark Therapeutics, Inc. (NASDAQ:AARD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Will Aardvark Therapeutics Inc. stock beat EPS estimates2025 Sector Review & Real-Time Buy Signal Notifications - newser.com
Using AI based signals to follow Aardvark Therapeutics Inc.Trade Analysis Summary & Real-Time Price Movement Reports - newser.com
Is Aardvark Therapeutics Inc. forming a bottoming baseVolume Spike & Weekly Breakout Watchlists - newser.com
Is Aardvark Therapeutics Inc. building a consolidation baseGap Down & Free Long-Term Investment Growth Plans - newser.com
Aardvark Therapeutics Advances PWS Treatment with ARD-101 Study - TipRanks
Aardvark Therapeutics’ ARD-101 Study: A New Hope for Prader-Willi Syndrome - TipRanks
Aardvark Therapeutics Inc (AARD) 재무 분석
Aardvark Therapeutics Inc (AARD)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):